
Welcome to
ONLiNE UPSC
The Indian SARS-CoV-2 Genomics Consortium, or INSACOG, represents a collaborative effort among various Indian health and research organizations. Its primary purpose is to analyze the genetic structure of the COVID-19 virus within India.
INSACOG was initiated by the Union Health Ministry, alongside the Department of Biotechnology (DBT), the Council for Scientific & Industrial Research (CSIR), and the Indian Council of Medical Research (ICMR).
INSACOG plays a crucial role in informing health policies, enabling the government to make informed decisions regarding pandemic management. It also assists in the development and updating of vaccines in response to viral mutations. Furthermore, INSACOG contributes to the global understanding of COVID-19.
INSACOG is vital to India's strategy against the COVID-19 pandemic, focusing on genomic surveillance.
INSACOG's contributions inform preventive measures and public health policies. Understanding variants is essential for assessing and improving vaccine efficacy. Additionally, INSACOG engages in international collaboration, enhancing global genomic knowledge.
INSACOG is pivotal to India's COVID-19 response, providing essential insights into the virus's evolution and supporting strategic health planning.
Q1. What is the main role of INSACOG?
Answer: INSACOG's primary role is to conduct genomic surveillance of the COVID-19 virus in India, studying its variants and impacts to inform public health strategies.
Q2. How many laboratories are part of INSACOG?
Answer: INSACOG comprises a network of 54 laboratories across India, working together to analyze the genetic makeup of the COVID-19 virus.
Q3. Why is genomic surveillance important?
Answer: Genomic surveillance helps track the evolution of SARS-CoV-2, allowing for early detection of variants and informed public health responses.
Q4. How does INSACOG contribute to vaccine development?
Answer: By analyzing viral variants, INSACOG aids in understanding vaccine efficacy and supports the development of updated vaccines in response to mutations.
Q5. What challenges does INSACOG face in its operations?
Answer: INSACOG encounters challenges related to resource allocation, effective public health integration, and the need to monitor global variants due to international travel.
Question 1: What is the primary function of INSACOG?
A) To conduct clinical trials
B) To perform genomic surveillance of COVID-19
C) To develop new vaccines
D) To manage public health policies
Correct Answer: B
Question 2: How many laboratories are involved in the INSACOG network?
A) 40
B) 54
C) 60
D) 70
Correct Answer: B
Kutos : AI Assistant!